RANOLAZINE ER 500 MG TABLET

RANOLAZINE
$0.1681per EA

Strength

500 mg/1

NDC

72319002102

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

RANOLAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA213517

On Market Since

6/15/2022

Pharmacological Classes

Anti-anginal
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
Organic Cation Transporter 2 Inhibitors
P-Glycoprotein Inhibitors

Price History

1W

0.0%

1M

+1.6%

3M

+3.2%

6M

+1.7%

1Y

-18.5%

3Y

-21.9%

5Y

N/A

All

-33.5%